Document Detail


Individualization of drug dosage during long-term treatment with phenprocoumon (Falithrom).
MedLine Citation:
PMID:  689796     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pharmacokinetic studies were carried out with 3H-phenprocoumon (3H-PPC) during long-term treatment with phenprocoumon (PPC, Falithrom) in 10 female and male patients with thromboembolic diseases. Additionally, 12 mg 3H-PPC were administered per os to 6 male volunteers. Half-life and pattern of urine metabolites were measured and compared with those in patients. The radioactivity decreased independently of the total PPC plasma concentration, which was estimated fluorometrically. An exponential regression with a high coefficient of determination was found between the mean maintenance dose (PPC) and the area under plasma concentration curve of radioactivity. This procedure is considered to be a method to improve long-term treatment with PPC.
Authors:
K O Haustein; M Richter; G Vogel; E Mittag
Related Documents :
1831816 - Disposition kinetics of orally administered enoximone in patients with moderate to seve...
8137596 - Clinical pharmacokinetics of tenoxicam.
6428916 - Elucidation of the structure and receptor binding studies of the major primary, metabol...
15640486 - Bioavailability and bioefficacy of polyphenols in humans. i. review of 97 bioavailabili...
14623486 - Detection of endocrine-modulating effects of the antithyroid acting drug 6-propyl-2-thi...
2485066 - Clinical and biochemical effects of the renin inhibitor h142 in humans.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of clinical pharmacology and biopharmacy     Volume:  16     ISSN:  0340-0026     ISO Abbreviation:  Int J Clin Pharmacol Biopharm     Publication Date:  1978 Aug 
Date Detail:
Created Date:  1978-11-18     Completed Date:  1978-11-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7505527     Medline TA:  Int J Clin Pharmacol Biopharm     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  372-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
4-Hydroxycoumarins / administration & dosage*
Adult
Female
Half-Life
Humans
Male
Middle Aged
Phenprocoumon / administration & dosage*,  blood
Prothrombin Time
Time Factors
Chemical
Reg. No./Substance:
0/4-Hydroxycoumarins; 435-97-2/Phenprocoumon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The distribution of sodium salicylate in the human fetus.
Next Document:  The relative bioavailability and pharmacokinetics of carbamazepine.